A robust platform for multiplexed, subcellular proteomic imaging in human tissue

用于人体组织多重亚细胞蛋白质组成像的强大平台

基本信息

  • 批准号:
    9894465
  • 负责人:
  • 金额:
    $ 59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-11 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Multiplexed Ion Beam Imaging by Time of Flight (MIBI-TOF) uses secondary ion mass spectrometry and metal conjugated primary antibodies to simultaneously visualize dozens of proteins at subcellular resolution in a single tissue section. This technology is back compatible with archival formalin fixed, paraffin embedded tissue (FFPE) and has been used in peer-reviewed work to simultaneously visualize and quantify 36 proteins in retrospective human tissue cohorts. In line with the stated goals of the HuBMAP consortium to develop both “High-sensitivity, high-resolution imaging techniques that can rapidly provide spectral data over large areas of tissue” and “Quantitative imaging analysis tools, including automated 3D image segmentation, feature extraction, and image annotation,” the work outlined here will create a standardized, high throughput, and user-friendly workflow for using MIBI-TOF in basic and translational research to gain insight into how single cell phenotype and tissue structure are functionally-linked in health and disease. To achieve this, we will validate 100 FFPE antibodies and optimize ready-to-use multiplexed staining panels in lyophilized format that will permit storage for at least two years. Protocols and reagents for multiplexed signal amplification of protein and mRNA targets will be further refined, while next generation instrumentation will increase sample throughput to permit full tissue section imaging of up to 40 proteins in 1 hour. Standardized reagents and more robust instrumentation will be accompanied by an automated computational pipeline that utilizes a standard set of segmentation markers and machine learning to accurately identify nuclei and cell borders in any non-neural human tissue. This data will be used to cluster single cell events into functionally distinct populations according to morphology, protein expression, and histological distribution. The reagents and computational pipeline proposed here synergize with existing HuBMAP-funded platforms and could be readily generalized to virtually any high dimensional imaging modality. Thus, this work will not only provide a practical, back compatible imaging platform for high throughput multiplexed imaging, but will also accelerate development of other complimentary imaging technologies as well.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert michael Angelo其他文献

Robert michael Angelo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert michael Angelo', 18)}}的其他基金

Multimodal histologic atlas of human bone marrow
人骨髓多模态组织学图谱
  • 批准号:
    10531005
  • 财政年份:
    2022
  • 资助金额:
    $ 59万
  • 项目类别:
Data Analysis, Integration, and Sharing Core
数据分析、整合、共享核心
  • 批准号:
    10531006
  • 财政年份:
    2022
  • 资助金额:
    $ 59万
  • 项目类别:
Multimodal histologic atlas of human bone marrow
人骨髓多模态组织学图谱
  • 批准号:
    10924351
  • 财政年份:
    2022
  • 资助金额:
    $ 59万
  • 项目类别:
Multimodal histologic atlas of human bone marrow
人骨髓多模态组织学图谱
  • 批准号:
    10673893
  • 财政年份:
    2022
  • 资助金额:
    $ 59万
  • 项目类别:
Project 2: Cellular topography and function of the breast cancer tissue microenvironment
项目2:乳腺癌组织微环境的细胞形态和功能
  • 批准号:
    10704687
  • 财政年份:
    2021
  • 资助金额:
    $ 59万
  • 项目类别:
Project 2: Cellular topography and function of the breast cancer tissue microenvironment
项目2:乳腺癌组织微环境的细胞形态和功能
  • 批准号:
    10272390
  • 财政年份:
    2021
  • 资助金额:
    $ 59万
  • 项目类别:
A robust platform for multiplexed, subcellular proteomic imaging in human tissue
用于人体组织多重亚细胞蛋白质组成像的强大平台
  • 批准号:
    10247827
  • 财政年份:
    2019
  • 资助金额:
    $ 59万
  • 项目类别:
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease
MIRIAD - 阿尔茨海默病恢复力的多重成像
  • 批准号:
    9974453
  • 财政年份:
    2017
  • 资助金额:
    $ 59万
  • 项目类别:
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam Imaging
下一代多重离子束成像揭示认知衰退的表型景观
  • 批准号:
    9910356
  • 财政年份:
    2017
  • 资助金额:
    $ 59万
  • 项目类别:
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease
MIRIAD - 阿尔茨海默病恢复力的多重成像
  • 批准号:
    9439172
  • 财政年份:
    2017
  • 资助金额:
    $ 59万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 59万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 59万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 59万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 59万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了